Research Feeds

View All
1H NMR- based metabolomics approaches as non-invasive tools for diagnosis of endometriosis A Comparative Study of Blood Levels of Manganese, Some Macroelements and Heavy Metals in Obese and Non-Obese Polycystic Ovary Syndrome Patients A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? A comprehensive analysis of breast cancer microbiota and host gene expression A comprehensive analysis of breast cancer microbiota and host gene expression A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women A metabonomics approach as a means for identification of potentialbiomarkers for early diagnosis of endometriosis A More Diverse Cervical Microbiome Associates with Better Clinical Outcomes in Patients with Endometriosis: A Pilot Study A Multi-Omic Systems-Based Approach Reveals Metabolic Markers of Bacterial Vaginosis and Insight into the Disease A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota A Review of the Anti-inflammatory Properties of Clindamycin in the Treatment of Acne Vulgaris A Systematic Review and Meta-Analysis of Premenstrual Syndrome with Special Emphasis on Herbal Medicine and Nutritional Supplements. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS)

The Positive Influence of Polyphenols Extracted From Pueraria lobata Root on the Gut Microbiota and Its Antioxidant Capability Original paper

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

March 18, 2025

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Last Updated: 2024

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

What Was Studied?

This study examined the effects of a polyphenol-rich extract derived from Pueraria lobata (commonly known as kudzu root) on gut microbiota composition and antioxidant activity in both in vitro and in vivo models. Using antioxidant assays and high-throughput sequencing, the researchers investigated the extract’s ability to modulate oxidative stress and alter microbial populations in the gut.

Who Was Studied?

The in vivo experiments involved male C57BL/6 mice divided into control and experimental groups. The experimental group received a daily dose of 200 mg/kg of the P. lobata extract for 30 days, while the control group received water. Fecal samples were collected for gut microbiota analysis, and liver tissue was assessed for oxidative stress markers.

What Were the Most Important Findings?

The study demonstrated that the Pueraria lobata extract significantly improved antioxidant status and gut microbiota composition in mice. It enhanced key antioxidant enzyme activities, such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and reduced markers of oxidative stress like malondialdehyde (MDA). In terms of gut microbiota, the extract increased beneficial taxa (e.g., Lactobacillaceae, Bacteroidetes, and Rikenellaceae) while suppressing harmful families (e.g., Ruminococcaceae, Prevotellaceae, and Burkholderiaceae). These changes included favorable shifts in the Firmicutes-to-Bacteroidetes ratio, a crucial metric for metabolic and immune health. Functional analyses predicted alterations in cellular and neurological health pathways, underscoring the systemic effects of gut microbiota modulation by the extract.

Antioxidant Effects of P. lobata Extract

ParameterChange Observed
Superoxide dismutase (SOD)Increased by 25.7%
Glutathione peroxidase (GSH-Px)Increased by 21.6%
Total antioxidant capacity (T-AOC)Increased by 13.6%
Malondialdehyde (MDA)Reduced by 33.9%

Gut Microbiota Effects of P. lobata Extract

TaxaChange Observed
LactobacillaceaeIncreased 1.64-fold
BacteroidetesIncreased 3.96-fold
RikenellaceaeIncreased 2.02-fold
RuminococcaceaeDecreased by 66.8%
PrevotellaceaeDecreased by 23.3%
BurkholderiaceaeDecreased by 73.6%
ErysipelotrichaceaeMarkedly reduced (>90%)
AkkermansiaceaeMarkedly reduced (>90%)

What Are the Greatest Implications of This Study?

The findings suggest that Pueraria lobata extract could serve as a natural antioxidant and prebiotic, offering potential applications in managing oxidative stress-related conditions and gut dysbiosis. Its ability to selectively enhance beneficial microbes and suppress harmful ones makes it a promising candidate for developing functional foods or therapeutic interventions for chronic diseases such as metabolic syndrome, obesity, and neurodegenerative disorders. Additionally, the observed dual benefits of antioxidative and gut microbiota modulation highlight its multifaceted therapeutic potential.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.